A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa

The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:AIDS patient care and STDs 2019-11, Vol.33 (11), p.466-472
Hauptverfasser: Le Roux, Karl W, Davis, Emily C, Gaunt, Charles Benjamin, Young, Catherine, Koussa, Maryann, Harris, Carl, Rotheram-Borus, Mary Jane
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 472
container_issue 11
container_start_page 466
container_title AIDS patient care and STDs
container_volume 33
creator Le Roux, Karl W
Davis, Emily C
Gaunt, Charles Benjamin
Young, Catherine
Koussa, Maryann
Harris, Carl
Rotheram-Borus, Mary Jane
description The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in the deeply rural Eastern Cape of South Africa. The Zithulele ART Program initiated five innovations over time: (1) establishing district hospital as the logistical hub for all ART care in a rural district, (2) primary care clinic delivery of prepackaged ART and chronic medications for people living with HIV (PLH), (3) establishing central record keeping, (4) incentivizing VL monitoring, and (5) providing hospital-based outpatient care for complex cases. Using a pharmacy database, on-time VL monitoring and viral suppression were evaluated for 882 PLH initiating ART in the Zithulele catchment area in 2013. Among PLH initiating ART, 12.5% (  = 110) were lost to follow-up, 7.7% (  = 68) transferred out of the region, 10.2% (  = 90) left the program and came back at a later date, and 4.0% (  = 35) died. Of the on-treatment population, 82.9% (  = 480/579) had VL testing within 7 months and 92.6% (  = 536/579) by 1 year. Viral suppression was achieved in 85.2% of those tested (  = 457/536), or 78.9% (  = 457/579) overall. The program's VL testing and suppression rates appear about twice as high as national data and data from other rural centers in South Africa, despite fewer resources than other programs. Simple system innovations can ensure high rates of VL testing and suppression, even in rural health facilities.
doi_str_mv 10.1089/apc.2019.0055
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6839417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2311741578</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-86463686360603b5226a732ef75c88108015f204d042148cb921194e65f58bcf3</originalsourceid><addsrcrecordid>eNpdkUtrGzEUhUVpaF5ddlsE3XQzjt7SbALGpE0gkFIna6GRpVhhPHIkjcH_PprmQZPFRVfcj3Pv4QDwDaMZRqo9M1s7Iwi3M4Q4_wSOMOeykYy1n2uPlGxIi9khOM75ASGkCEdfwCHFQhEs5BEwc7gw2cFlGVd7GD00A7zw3tkSdq5-VnA55mLCYLrewflQQnIlxV1Ipoe3a5fMdg__pHifzAaGAf4dp8EyjmUN5z4Fa07BgTd9dl9f3hNw9-vidnHZXN_8vlrMrxvLMC-NEkxQoWohgWjHCRFGUuK85Fap6gRh7gliK8QIZsp2LcG4ZU5wz1VnPT0B58-627HbuJV1Q6mn6G0KG5P2Opqg30-GsNb3caeFoi3Dsgr8fBFI8XF0uehNyNb1vRlcHLMmtC4kVIoJ_fEBfYhjGqq9f5SsjqSqVPNM2RRzTs6_HYORnsLTNTw9haen8Cr__X8Hb_RrWvQJnCyTpw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2311741578</pqid></control><display><type>article</type><title>A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Le Roux, Karl W ; Davis, Emily C ; Gaunt, Charles Benjamin ; Young, Catherine ; Koussa, Maryann ; Harris, Carl ; Rotheram-Borus, Mary Jane</creator><creatorcontrib>Le Roux, Karl W ; Davis, Emily C ; Gaunt, Charles Benjamin ; Young, Catherine ; Koussa, Maryann ; Harris, Carl ; Rotheram-Borus, Mary Jane</creatorcontrib><description>The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in the deeply rural Eastern Cape of South Africa. The Zithulele ART Program initiated five innovations over time: (1) establishing district hospital as the logistical hub for all ART care in a rural district, (2) primary care clinic delivery of prepackaged ART and chronic medications for people living with HIV (PLH), (3) establishing central record keeping, (4) incentivizing VL monitoring, and (5) providing hospital-based outpatient care for complex cases. Using a pharmacy database, on-time VL monitoring and viral suppression were evaluated for 882 PLH initiating ART in the Zithulele catchment area in 2013. Among PLH initiating ART, 12.5% (  = 110) were lost to follow-up, 7.7% (  = 68) transferred out of the region, 10.2% (  = 90) left the program and came back at a later date, and 4.0% (  = 35) died. Of the on-treatment population, 82.9% (  = 480/579) had VL testing within 7 months and 92.6% (  = 536/579) by 1 year. Viral suppression was achieved in 85.2% of those tested (  = 457/536), or 78.9% (  = 457/579) overall. The program's VL testing and suppression rates appear about twice as high as national data and data from other rural centers in South Africa, despite fewer resources than other programs. Simple system innovations can ensure high rates of VL testing and suppression, even in rural health facilities.</description><identifier>ISSN: 1087-2914</identifier><identifier>EISSN: 1557-7449</identifier><identifier>DOI: 10.1089/apc.2019.0055</identifier><identifier>PMID: 31682167</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Adult ; AIDS/HIV ; Ambulatory Care Facilities ; Anti-HIV Agents - therapeutic use ; Antiretroviral agents ; Antiretroviral drugs ; Antiretroviral therapy ; Antiretroviral Therapy, Highly Active ; Catchment areas ; Clinical and Epidemiologic Research ; Community Health Centers ; Delivery of Health Care - organization &amp; administration ; Drug therapy ; Female ; Health care ; Health care facilities ; HIV ; HIV Infections - drug therapy ; HIV Infections - virology ; HIV Seropositivity - drug therapy ; Hospital facilities ; Human immunodeficiency virus ; Humans ; Male ; Medical innovations ; Monitoring ; Program Evaluation ; Rural areas ; Rural communities ; Rural Health Services - statistics &amp; numerical data ; Rural Population ; South Africa - epidemiology ; Therapy ; Treatment Outcome ; Viral Load</subject><ispartof>AIDS patient care and STDs, 2019-11, Vol.33 (11), p.466-472</ispartof><rights>Copyright Mary Ann Liebert, Inc. Nov 2019</rights><rights>Copyright 2019, Mary Ann Liebert, Inc., publishers 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-86463686360603b5226a732ef75c88108015f204d042148cb921194e65f58bcf3</citedby><cites>FETCH-LOGICAL-c415t-86463686360603b5226a732ef75c88108015f204d042148cb921194e65f58bcf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31682167$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Le Roux, Karl W</creatorcontrib><creatorcontrib>Davis, Emily C</creatorcontrib><creatorcontrib>Gaunt, Charles Benjamin</creatorcontrib><creatorcontrib>Young, Catherine</creatorcontrib><creatorcontrib>Koussa, Maryann</creatorcontrib><creatorcontrib>Harris, Carl</creatorcontrib><creatorcontrib>Rotheram-Borus, Mary Jane</creatorcontrib><title>A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa</title><title>AIDS patient care and STDs</title><addtitle>AIDS Patient Care STDS</addtitle><description>The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in the deeply rural Eastern Cape of South Africa. The Zithulele ART Program initiated five innovations over time: (1) establishing district hospital as the logistical hub for all ART care in a rural district, (2) primary care clinic delivery of prepackaged ART and chronic medications for people living with HIV (PLH), (3) establishing central record keeping, (4) incentivizing VL monitoring, and (5) providing hospital-based outpatient care for complex cases. Using a pharmacy database, on-time VL monitoring and viral suppression were evaluated for 882 PLH initiating ART in the Zithulele catchment area in 2013. Among PLH initiating ART, 12.5% (  = 110) were lost to follow-up, 7.7% (  = 68) transferred out of the region, 10.2% (  = 90) left the program and came back at a later date, and 4.0% (  = 35) died. Of the on-treatment population, 82.9% (  = 480/579) had VL testing within 7 months and 92.6% (  = 536/579) by 1 year. Viral suppression was achieved in 85.2% of those tested (  = 457/536), or 78.9% (  = 457/579) overall. The program's VL testing and suppression rates appear about twice as high as national data and data from other rural centers in South Africa, despite fewer resources than other programs. Simple system innovations can ensure high rates of VL testing and suppression, even in rural health facilities.</description><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Ambulatory Care Facilities</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral agents</subject><subject>Antiretroviral drugs</subject><subject>Antiretroviral therapy</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Catchment areas</subject><subject>Clinical and Epidemiologic Research</subject><subject>Community Health Centers</subject><subject>Delivery of Health Care - organization &amp; administration</subject><subject>Drug therapy</subject><subject>Female</subject><subject>Health care</subject><subject>Health care facilities</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - virology</subject><subject>HIV Seropositivity - drug therapy</subject><subject>Hospital facilities</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Male</subject><subject>Medical innovations</subject><subject>Monitoring</subject><subject>Program Evaluation</subject><subject>Rural areas</subject><subject>Rural communities</subject><subject>Rural Health Services - statistics &amp; numerical data</subject><subject>Rural Population</subject><subject>South Africa - epidemiology</subject><subject>Therapy</subject><subject>Treatment Outcome</subject><subject>Viral Load</subject><issn>1087-2914</issn><issn>1557-7449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtrGzEUhUVpaF5ddlsE3XQzjt7SbALGpE0gkFIna6GRpVhhPHIkjcH_PprmQZPFRVfcj3Pv4QDwDaMZRqo9M1s7Iwi3M4Q4_wSOMOeykYy1n2uPlGxIi9khOM75ASGkCEdfwCHFQhEs5BEwc7gw2cFlGVd7GD00A7zw3tkSdq5-VnA55mLCYLrewflQQnIlxV1Ipoe3a5fMdg__pHifzAaGAf4dp8EyjmUN5z4Fa07BgTd9dl9f3hNw9-vidnHZXN_8vlrMrxvLMC-NEkxQoWohgWjHCRFGUuK85Fap6gRh7gliK8QIZsp2LcG4ZU5wz1VnPT0B58-627HbuJV1Q6mn6G0KG5P2Opqg30-GsNb3caeFoi3Dsgr8fBFI8XF0uehNyNb1vRlcHLMmtC4kVIoJ_fEBfYhjGqq9f5SsjqSqVPNM2RRzTs6_HYORnsLTNTw9haen8Cr__X8Hb_RrWvQJnCyTpw</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Le Roux, Karl W</creator><creator>Davis, Emily C</creator><creator>Gaunt, Charles Benjamin</creator><creator>Young, Catherine</creator><creator>Koussa, Maryann</creator><creator>Harris, Carl</creator><creator>Rotheram-Borus, Mary Jane</creator><general>Mary Ann Liebert, Inc</general><general>Mary Ann Liebert, Inc., publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7T5</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201911</creationdate><title>A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa</title><author>Le Roux, Karl W ; Davis, Emily C ; Gaunt, Charles Benjamin ; Young, Catherine ; Koussa, Maryann ; Harris, Carl ; Rotheram-Borus, Mary Jane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-86463686360603b5226a732ef75c88108015f204d042148cb921194e65f58bcf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Ambulatory Care Facilities</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral agents</topic><topic>Antiretroviral drugs</topic><topic>Antiretroviral therapy</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Catchment areas</topic><topic>Clinical and Epidemiologic Research</topic><topic>Community Health Centers</topic><topic>Delivery of Health Care - organization &amp; administration</topic><topic>Drug therapy</topic><topic>Female</topic><topic>Health care</topic><topic>Health care facilities</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - virology</topic><topic>HIV Seropositivity - drug therapy</topic><topic>Hospital facilities</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Male</topic><topic>Medical innovations</topic><topic>Monitoring</topic><topic>Program Evaluation</topic><topic>Rural areas</topic><topic>Rural communities</topic><topic>Rural Health Services - statistics &amp; numerical data</topic><topic>Rural Population</topic><topic>South Africa - epidemiology</topic><topic>Therapy</topic><topic>Treatment Outcome</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Le Roux, Karl W</creatorcontrib><creatorcontrib>Davis, Emily C</creatorcontrib><creatorcontrib>Gaunt, Charles Benjamin</creatorcontrib><creatorcontrib>Young, Catherine</creatorcontrib><creatorcontrib>Koussa, Maryann</creatorcontrib><creatorcontrib>Harris, Carl</creatorcontrib><creatorcontrib>Rotheram-Borus, Mary Jane</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>AIDS patient care and STDs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Le Roux, Karl W</au><au>Davis, Emily C</au><au>Gaunt, Charles Benjamin</au><au>Young, Catherine</au><au>Koussa, Maryann</au><au>Harris, Carl</au><au>Rotheram-Borus, Mary Jane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa</atitle><jtitle>AIDS patient care and STDs</jtitle><addtitle>AIDS Patient Care STDS</addtitle><date>2019-11</date><risdate>2019</risdate><volume>33</volume><issue>11</issue><spage>466</spage><epage>472</epage><pages>466-472</pages><issn>1087-2914</issn><eissn>1557-7449</eissn><abstract>The delivery of high-quality HIV care in rural settings is a global challenge. Despite the successful expansion of antiretroviral therapy (ART) in Africa, viral load (VL) monitoring and ART adherence are poor, especially in rural communities. This article describes a case study of an ART program in the deeply rural Eastern Cape of South Africa. The Zithulele ART Program initiated five innovations over time: (1) establishing district hospital as the logistical hub for all ART care in a rural district, (2) primary care clinic delivery of prepackaged ART and chronic medications for people living with HIV (PLH), (3) establishing central record keeping, (4) incentivizing VL monitoring, and (5) providing hospital-based outpatient care for complex cases. Using a pharmacy database, on-time VL monitoring and viral suppression were evaluated for 882 PLH initiating ART in the Zithulele catchment area in 2013. Among PLH initiating ART, 12.5% (  = 110) were lost to follow-up, 7.7% (  = 68) transferred out of the region, 10.2% (  = 90) left the program and came back at a later date, and 4.0% (  = 35) died. Of the on-treatment population, 82.9% (  = 480/579) had VL testing within 7 months and 92.6% (  = 536/579) by 1 year. Viral suppression was achieved in 85.2% of those tested (  = 457/536), or 78.9% (  = 457/579) overall. The program's VL testing and suppression rates appear about twice as high as national data and data from other rural centers in South Africa, despite fewer resources than other programs. Simple system innovations can ensure high rates of VL testing and suppression, even in rural health facilities.</abstract><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>31682167</pmid><doi>10.1089/apc.2019.0055</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1087-2914
ispartof AIDS patient care and STDs, 2019-11, Vol.33 (11), p.466-472
issn 1087-2914
1557-7449
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6839417
source MEDLINE; Alma/SFX Local Collection
subjects Adult
AIDS/HIV
Ambulatory Care Facilities
Anti-HIV Agents - therapeutic use
Antiretroviral agents
Antiretroviral drugs
Antiretroviral therapy
Antiretroviral Therapy, Highly Active
Catchment areas
Clinical and Epidemiologic Research
Community Health Centers
Delivery of Health Care - organization & administration
Drug therapy
Female
Health care
Health care facilities
HIV
HIV Infections - drug therapy
HIV Infections - virology
HIV Seropositivity - drug therapy
Hospital facilities
Human immunodeficiency virus
Humans
Male
Medical innovations
Monitoring
Program Evaluation
Rural areas
Rural communities
Rural Health Services - statistics & numerical data
Rural Population
South Africa - epidemiology
Therapy
Treatment Outcome
Viral Load
title A Case Study of an Effective and Sustainable Antiretroviral Therapy Program in Rural South Africa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T17%3A35%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Case%20Study%20of%20an%20Effective%20and%20Sustainable%20Antiretroviral%20Therapy%20Program%20in%20Rural%20South%20Africa&rft.jtitle=AIDS%20patient%20care%20and%20STDs&rft.au=Le%20Roux,%20Karl%20W&rft.date=2019-11&rft.volume=33&rft.issue=11&rft.spage=466&rft.epage=472&rft.pages=466-472&rft.issn=1087-2914&rft.eissn=1557-7449&rft_id=info:doi/10.1089/apc.2019.0055&rft_dat=%3Cproquest_pubme%3E2311741578%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2311741578&rft_id=info:pmid/31682167&rfr_iscdi=true